Skip to main content
Fig. 2 | BMC Medical Genetics

Fig. 2

From: An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma

Fig. 2

Kaplan-Meier survival curves and the receiver operating characteristic curve (AUC) to evaluate predictive performance of the prognosis prediction models based on expression status of the selected biomarkers in the training set and the validation set. a, selected ten lncRNAs; b, selected eight mRNAs. All patients in each set are classified by each prognostic model into a high-risk group and a low-risk group

Back to article page